Evidence map›Paper›PMID 41885416›Full record

ArticleApplied and environmental microbiology2026

Adaptation of the multiplexed CRISPR-Cas13 CARMEN RVP assay for longitudinal detection of respiratory pathogens from air samples.

Amy L Ellis, Miranda Stauss, Patrick Barros Tiburcio, Isla E Emmen, Paul T Edlefsen, Ewelina Kosmider, Shari Barlow, Maureen Goss, Jonathan L Temte, Elyse Stachler and 4 more

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Amy L EllisDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0002-6503-1399
Miranda StaussWisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Patrick Barros TiburcioDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Isla E EmmenDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Paul T EdlefsenFred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA.
Ewelina KosmiderFred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA.
Shari BarlowDepartment of Family Medicine and Community Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Maureen GossDepartment of Family Medicine and Community Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Jonathan L TemteDepartment of Family Medicine and Community Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0001-7097-583X
Elyse StachlerDepartment of Organismic and Evolutionary Biology, Broad Institute of MIT and Harvard, Harvard University, Cambridge, Massachusetts, USA.ORCID 0000-0002-4961-1983
Kyle McMahonDepartment of Organismic and Evolutionary Biology, Broad Institute of MIT and Harvard, Harvard University, Cambridge, Massachusetts, USA.ORCID 0009-0004-6515-0365
Pardis SabetiDepartment of Organismic and Evolutionary Biology, Broad Institute of MIT and Harvard, Harvard University, Cambridge, Massachusetts, USA.ORCID 0000-0002-9843-1890
David H O'ConnorDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0003-2139-470X
Shelby L O'ConnorDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0003-0183-5010

Funding

Centers for Disease Control and Prevention Foundation 5U01CK000542-02-00Centers for Disease Control and Prevention Foundation 6U01CK000630-01-01NIH HHS 5R01AI170737
6 · The paper itself

Abstract

Air sampling is a non-invasive alternative to individual testing for respiratory pathogens. Alternative methods to the "gold standard" quantitative reverse transcription-PCR (qRT-PCR) are required to enable higher throughput, lower cost, and more multiplexed detection of pathogens. The multiplexed CRISPR-Cas13 CARMEN Respiratory Viral Panel (RVP) was described previously for high-throughput detection of nine respiratory pathogens from nasal swab samples. Here, we modified and optimized the CARMEN RVP assay to overcome the unique challenges of air samples, including low biomass and environmental inhibitors. We monitored for SARS-CoV-2 and influenza A (Flu A) via qRT-PCR in air samples from 15 schools within Dane County, Wisconsin (USA), during the 2023-2024 school year. SARS-CoV-2 was detectable throughout the entire sampling period, while Flu A detection was seasonal from November 2023 to March 2024. We then analyzed a subset of samples from seven schools using an optimized CARMEN RVP assay for air surveillance (RVP_air) and compared the results to qRT-PCR. The RVP_air assay detected several additional pathogens beyond our primary targets. The frequencies and patterns of SARS-CoV-2 positivity, but not Flu A positivity, were similar between qRT-PCR and RVP_air across the 2023-2024 sampling period. We developed a secondary panel (RVP_air_flu) to better detect both H1N1 and H3N2 subtypes. Finally, we compared air sample results to clinical nasal swabs collected from the same school district. For several pathogens (SARS-CoV-2, HCoV-OC43, Flu A), positive air detections coincided with positive nasal swabs. These findings demonstrate that the RVP_air assay can effectively detect airborne pathogens from infected individuals within indoor spaces. IMPORTANCE: Air sampling offers a cost-effective alternative to individual testing for respiratory pathogens within congregate settings. Optimization and use of multi-pathogen assays are especially valuable for capturing the breadth of pathogens that may be present simultaneously in the same space. The modified CARMEN RVP assays (RVP_air and RVP_air_flu) detected SARS-CoV-2 and Flu A during similar sampling time periods compared to qRT-PCR, while also detecting several additional respiratory pathogens (seasonal coronaviruses, respiratory syncytial virus). Importantly, pathogens detected from air samples corresponded to those detected from nasal swabs collected from individuals in the same spaces. Together, these findings highlight the utility of the RVP_air and RVP_air_flu assays as alternatives to qRT-PCR for environmental surveillance, with applications extending to other congregate spaces (hospitals, long-term care facilities) and high-risk settings, better informing communities and improving public health.

Indexed as

Air MicrobiologyCRISPR-Cas SystemsInfluenza A virusSARS-CoV-2COVID-19HumansSchoolsWisconsinair samplingenvironmental surveillancepublic health

Identifiers

PMID41885416
PMCPMC13101527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.